Death due to intravenous use of α-pyrrolidinopentiophenone.
Prince of Wales Hospital, Sydney, NSW, Australia. kate.sellors@sesiahs.health.nsw.gov.au.
Kate
K
Sellors
Graduate School of Medicine, University of Wollongong, Wollongong, NSW, Australia.
Alison
A
Jones
Prince of Wales Hospital, Sydney, NSW, Australia.
Betty
B
Chan
D000328:Adult; D002544:Cerebral Infarction / Q000139:chemically induced; D015198:Designer Drugs / Q000009:adverse effects; D004677:Encephalocele / Q000139:chemically induced; D006323:Heart Arrest / Q000139:chemically induced*; D006801:Humans; D008297:Male; D011427:Propiophenones / Q000009:adverse effects / Q000633:toxicity*; D011619:Psychotropic Drugs / Q000009:adverse effects*; D011759:Pyrrolidines / Q000009:adverse effects / Q000633:toxicity*
D015198:Designer Drugs; D011427:Propiophenones; D011619:Psychotropic Drugs; D011759:Pyrrolidines; C487966:alpha-pyrrolidinopropiophenone